Eliem Therapeutics, (id:6862 ELYM)
3.05 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 1:20:41 AM)
Exchange closed, opens in 1 day 8 hours
0.66 USD (0.66%)
0.99 USD (0.99%)
-40.31 USD (-40.31%)
-59.44 USD (-59.44%)
15.53 USD (15.53%)
-81.23 USD (-81.23%)
About Eliem Therapeutics,
Market Capitalization 342.68M
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
| Headquarters (address) |
PMB #117, 2801 Centerville Road Wilmington 19808-1609 DE United States |
| Phone | 877 354 3689 |
| Website | https://eliemtx.com |
| Employees | 9 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | ELYM |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 2.35 - 11.55 |
| Market Capitalization | 342.68M |
| P/E trailing | -2.35 |
| P/E forward | -9.83 |
| Price/Book | 1.54 |
| Beta | -0.382 |
| EPS | -2.22 |
| EPS United States (ID:6, base:3403) | 24.22 |